Welcome to our dedicated page for Ambiq Micro SEC filings (Ticker: AMBQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ambiq Micro, Inc. (NYSE: AMBQ) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a fabless semiconductor company focused on ultra-low-power edge AI solutions, Ambiq uses these filings to report material events, financial results, governance changes, and equity compensation matters related to its SPOT®-based technology business.
Investors can review Form 8-K current reports in which Ambiq furnishes quarterly earnings press releases, detailing net sales, gross profit, operating expenses, net loss, and non-GAAP measures such as non-GAAP gross profit and non-GAAP net loss. These filings also describe business drivers like product mix, geographic revenue shifts, and demand for Apollo and other edge AI platforms. Additional 8-K items document events such as the completion of Ambiq’s initial public offering on the New York Stock Exchange and subsequent board and executive compensation decisions.
Over time, users can expect this page to include annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically provide more detailed discussions of Ambiq’s SPOT technology, Apollo and Atomiq product families, risk factors, and management’s analysis of financial condition and results of operations. These core filings are central for understanding how Ambiq describes its ultra-low-power edge AI strategy and market exposure.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify important changes in revenue trends, operating expenses, or capital structure. The platform also tracks insider-related filings such as Form 4, where available, so users can monitor equity awards and transactions involving Ambiq’s directors and executive officers.
By combining real-time updates from EDGAR with AI-generated insights, this page offers a focused view into AMBQ’s regulatory history, financial reporting practices, and governance developments, all grounded in the company’s official SEC submissions.
Ambiq Micro, Inc. General Counsel Michele Kim Connors reported routine share dispositions tied to tax withholding. On April 2, 2026, she disposed of a total of 811 shares of Common Stock in transactions used to satisfy her tax withholding obligations upon vesting and settlement of previously reported restricted stock units.
The reported weighted average prices were $26.0385 for 660 shares and $26.6509 for 151 shares, executed across multiple trades within disclosed price ranges. After these transactions, she continued to hold 60,554 shares of Ambiq Micro common stock directly, indicating that the dispositions represented a small portion of her overall holdings and were mechanically driven by tax requirements rather than discretionary open‑market selling.
Ambiq Micro, Inc. Chief Financial Officer Jeffrey G. Winzeler received a grant of 41,728 shares of Common Stock in the form of restricted stock units at no cash cost. Each RSU converts into one share of common stock when it vests.
According to the award terms, 25% of the RSUs will vest on October 1, 2027, and the remaining units will vest in equal quarterly installments thereafter, contingent on his continued service under the company’s 2025 Equity Incentive Plan. Following this grant, Winzeler directly holds 94,395 shares of Ambiq Micro common stock.
Chen Sean Chihhsiang reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro, Inc. reported that President and COO Sean Chihhsiang Chen received an equity grant of 64,246 shares of common stock in the form of restricted stock units. These RSUs were granted at no cash purchase price and increase his direct holdings to 120,275 shares after the award.
Each RSU represents a contingent right to receive one share of Ambiq Micro common stock upon settlement. According to the vesting schedule, 25% of the RSUs will vest on October 1, 2027, and the remaining shares will vest in equal quarterly installments over the following three years, as long as Chen maintains continuous service under the company’s 2025 Equity Incentive Plan.
Hanson Scott McLean reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro Chief Technology Officer Hanson Scott McLean received a grant of 80,308 shares of common stock in the form of restricted stock units (RSUs). The award was recorded at a price of $0.00 per share as equity compensation, not a market purchase. Following this grant, he directly holds 203,126 shares of Ambiq Micro common stock. According to the award terms, 25% of the RSUs will vest on October 1, 2027, and the remaining shares will vest in equal quarterly installments over three years, contingent on his continued service under the company’s 2025 Equity Incentive Plan.
Ambiq Micro, Inc.’s Chief Executive Officer, Esaka Fumihide, received a grant of 160,616 shares of common stock in the form of restricted stock units. The award carries no cash exercise price and is part of equity compensation, not an open-market purchase.
According to the terms, 25% of the RSUs will vest on October 1, 2027, and the remaining 75% will vest in equal quarterly installments of 1/12 thereafter, so long as he maintains Continuous Service under Ambiq’s 2025 Equity Incentive Plan. Following this grant, he directly holds 391,189 shares of common stock.
Connors Michele Kim reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro, Inc. reported that its General Counsel, Michele Kim Connors, received a grant of 32,123 shares of Common Stock in the form of restricted stock units (RSUs) at no cash cost. Following this equity award, she holds 61,365 shares directly.
Each RSU represents a right to receive one share of Common Stock upon settlement. According to the vesting schedule, 25% of the RSUs will vest on October 1, 2027, with the remaining RSUs vesting in equal quarterly installments over three years, contingent on her continued service under the company’s 2025 Equity Incentive Plan.
Connors Michele Kim reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro, Inc. General Counsel Michele Kim Connors received a grant of 32,123 shares of common stock in the form of restricted stock units. Following this award, she holds 61,365 common shares directly. Each RSU represents the right to receive one share upon settlement.
According to the grant terms, 25% of the RSUs will vest on September 1, 2027, and the remaining units will vest in quarterly installments of 1/12 thereafter, conditioned on her continued service under the company’s 2025 Equity Incentive Plan.
Winzeler Jeffrey G reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro, Inc. reported that Chief Financial Officer Jeffrey G. Winzeler received an equity grant in the form of 41,728 restricted stock units (RSUs) of common stock. The award has no cash purchase price and is part of his compensation rather than an open-market transaction.
Each RSU represents a right to receive one share of common stock upon settlement. According to the vesting schedule, 25% of the units will vest on September 1, 2027, and the remaining units will vest in equal quarterly installments over the following three years, subject to his continuous service under the 2025 Equity Incentive Plan. After this grant, Winzeler directly holds 94,395 shares of Ambiq common stock.
Chen Sean Chihhsiang reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro, Inc. President and COO Sean Chihhsiang Chen received an equity grant of 64,246 shares of common stock in the form of restricted stock units. The award was granted at no cash cost and increased his directly held common stock position to 120,275 shares.
Each RSU represents one share of common stock upon settlement. According to the vesting schedule, 25% of the RSUs will vest on September 1, 2027, with the remaining units vesting in equal quarterly installments over the following three years, subject to his continuous service under the company’s 2025 Equity Incentive Plan.
Hanson Scott McLean reported acquisition or exercise transactions in this Form 4 filing.
Ambiq Micro, Inc. director and Chief Technology Officer Scott McLean received a grant of 80,308 restricted stock units of Common Stock as equity compensation. These RSUs vest over time, with 25% vesting on September 1, 2027 and the remainder vesting quarterly thereafter, contingent on continued service. Following this award, McLean directly holds 203,126 shares of Common Stock.